Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.

Heart disease (Hagerstown, Md.), 2001 - europepmc.org
Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …
被引用次数：85 相关文章

Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade

WH Frishman, M Kowalski, S Nagnur… - Heart disease …, 2001 - pubmed.ncbi.nlm.nih.gov
Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

[引用][C] Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on β-adrenergic …

F WH - Heart Dis, 2001 - cir.nii.ac.jp
Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of
glaucoma and ocular hypertension : focus on β-adrenergic blockade | CiNii Research CiNii …

[引用][C] Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on β-adrenergic …

F WH - Heart Dis, 2001 - cir.nii.ac.jp
Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment
of glaucoma and ocular hypertension : focus on β-adrenergic blockade | CiNii Research …